跳至主要内容
临床试验/CTRI/2010/091/001118
CTRI/2010/091/001118已完成3 期

A randomized, double blind, placebo controlled, cross over, multicentric study to assess the efficacy and safety of Dapoxetine tablets in patients suffering from premature ejaculation

Cadila Healthcare Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male patients of 18 to 60 years of age.
  • 2.Stable, monogamous sexual relationship with a female partner
  • 3.Established diagnosis of premature ejaculation (PE)
  • 4.Informed consent

排除标准

  • 1.Erectile dysfunction or other forms of sexual dysfunction.
  • 2.Patients whose partners have problems of self-reported sexual dysfunction.
  • 3.History of major psychiatric disorder.
  • 4.Other significant pathological cardiac conditions
  • 5.Concomitant treatment which is not permissible
  • 6.History of orthostatic hypotension, seizures, lactose intolerance, hepatic or renal impairment.
  • 7.Patients with known hypersensitivity to SSRIs.
  • 8.Patients with any other serious concurrent illness or malignancy.
  • 9.Patients with continuing history of alcohol and / or drug abuse.
  • 10.Participation in another clinical trial in the past 3 months.

研究者

相似试验